ANI Pharmaceuticals News and Activities

Presence

ANI Pharmaceuticals develops and manufactures prescription medicines, including branded, generic, and rare disease therapies. It serves hospitals, pharmacies, and healthcare providers in the United States.

ANI Pharmaceuticals products and services overview:

Generic medicines
Branded medicines
Rare disease therapies
Sterile injectables
Oral solid drugs

Revenue: ~$598 million

Employees: 1,400

Headquarters: Baudette, United States (USA)

ANI Pharmaceuticals is one of the...

ANI Pharmaceuticals is a company listed under the stock ticker ANIP (US).

ANI Pharmaceuticals has a direct presence in 2 countries.

They are in:

Biotechnology50%
Pharmaceuticals50%

Acquisition, funding and merger involving ANI Pharmaceuticals.

ANI Pharmaceuticals has acquired Alimera Sciences (posted on September 16 2024).
ANI Pharmaceuticals has announced the acquisition of Alimera Sciences (posted on June 26 2024).

Executives

View the org chart displaying its 39 main executives

Most searched biographies at ANI Pharmaceuticals

Popular executive movements at ANI Pharmaceuticals

Patrick Walsh, who is Chairman of The Board will soon retire (posted on December 1 2025).
Thomas Haughey who is Director, will be promoted to Chairman of the Board (posted on December 1 2025).

Create your alert
to follow the executive moves at ANI Pharmaceuticals.